|
Adverse Effects
Citations 91-100 of 594 total displayed.
|
Past content
(since Mar 1998):
|
- Letters
Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients
- Javier Cortes; Cristina Saura; Francesco Atzori
JAMA 2009; 301: 1434-a-1435-a.
[Extract]
[Full text]
[PDF]
- Letters
Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients
- David R. Minor
JAMA 2009; 301: 1434.
[Extract]
[Full text]
[PDF]
- Letters
Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients—Reply
- David Chu; Shenhong Wu
JAMA 2009; 301: 1435-a-1436-a.
[Extract]
[Full text]
[PDF]
- Letters
Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients
- Saadettin Kilickap; Cagatay Arslan
JAMA 2009; 301: 1435.
[Extract]
[Full text]
[PDF]
- Lab Reports
Platelets and Malaria
- Joan Stephenson
JAMA 2009; 301: 1329-a.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Efforts Aim to Curb Opioid Deaths, Injuries
- Bridget M. Kuehn
JAMA 2009; 301: 1213-1215.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Sepsis Drug Risks
- Bridget M. Kuehn
JAMA 2009; 301: 1217-b.
[Extract]
[Full text]
[PDF]
- Letters
Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease
- Henry D. Covelli
JAMA 2009; 301: 1223-a.
[Extract]
[Full text]
[PDF]
- Letters
Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease
- Yuji Oba
JAMA 2009; 301: 1223.
[Extract]
[Full text]
[PDF]
- Letters
Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease
- Katherine E. Hodgin; James P. Maloney
JAMA 2009; 301: 1224-a.
[Extract]
[Full text]
[PDF]
|
|
